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Abstract
Silver Russell Syndrome (SRS) syndrome is an imprinting disorder involving low birth weight with complex genetics and
diagnostics. Some rare SRS patients carry maternally inherited microduplications spanning the imprinted genes CDKN1C,
PHLDA2, SLC22A18 and KCNQ1, suggesting that overexpression of one of more of these genes contributes to the SRS
phenotype. While this molecular alteration is very rare, feeding difficulties are a very common feature of this condition.
Given that SRS children also have very low body mass index, understanding the underpinning biology of the eating disorder
is important, as well as potential co-occurring behavioural alterations. Here, we report that a mouse model of this microdu-
plication exhibits a number of behavioural deficits. The mice had a blunted perception of the palatability of a given foodstuff.
This perception may underpin the fussiness with food. We additionally report hypoactivity, unrelated to anxiety or motoric
function, and a deficit in the appropriate integration of incoming sensory information. Importantly, using a second genetic
model, we were able to attribute all altered behaviours to elevated expression of a single gene, Cdkn1c. This is the first report
linking elevated Cdkn1c to altered behaviour in mice. Importantly, the findings from our study may have relevance for SRS
and highlight a potentially underreported aspect of this disorder.
Introduction
Silver Russell syndrome (SRS) is a very rare genetic disorder with
an approximate frequency of 1 in 300,000 (OMIM #180860).
The key characteristics that define SRS are foetal growth restric-
tion and failure to thrive postnatally, resulting in a lifelong deficit
in height and weight (1–4). While growth restriction is a relatively
common generic characteristic that can occur in a number of dis-
orders, SRS patients can be further characterised by some or all
of the following: a normal head circumference, which appears
large for the body, a large protruding forehead with a triangular-
shaped face, clinodactyly, undergrowth of one side of the body
(hemihypotrophy), fasting hypoglycaemia, night sweats and
excessive thinness which persists into adulthood. A recent clini-
cal scoring system has been proposed for SRS that encompasses
a number of these symptoms (4).
The cognitive and behavioural characteristics of SRS are
not clear. Some studies indicate normal intelligence and cogni-
tive ability (5–8) while others suggest specific learning difficulties
(9–12). There are reports of hyperactivity, emotional problems,
conduct problems as well as peer problems with similarities to
attention deficit hyperactivity disorder and social communica-
tion difficulties with akin to Autism Spectrum Disorders.
Although some studies suggest that behavioural problems in-
volving hyperactivity are relatively uncommon (2), one of the
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first descriptions of SRS reported hyperactivity (13) and one
study has reported issues with maintaining attention (11).
A more common behavioural observation in SRS centres on
feeding issues. Parents of SRS children often express concerns
about their child’s eating habits reporting poor appetite, fussy
eating and the struggle to get their SRS child to gain weight.
Studies reporting poor appetites and/or eating a limited variety
of food and/or having issues with food textures reported
frequencies of 30% (14), 60% (15), 67% (16) and 82% (17). A recent
study using the Netchine-Harbison clinical scoring system re-
ported 100% prevalence of feeding difficulties and/or
BMI <2SDS in children with a defined SRS (epi)mutation and
92.3% of children meeting the criteria for SRS without a defined
(epi)mutations (18) indicating major issues around healthy eat-
ing and weight gain.
While some researchers consider SRS a single condition,
there are a wide-range of both genetic and epigenetic mutations
reported in these patients which may account for differences in
their presentation, as suggested in the recent clinical diagnostic
scoring system (4). Approximately 70% of patients have alter-
ations affecting human chromosome 7 or 11 while the remaining
30% are of unknown origin (4). Both chromosomes 7 and 11 con-
tain imprinted genes, which are uniquely expressed from either
the paternal or maternal chromosome as a consequence of epi-
genetic marks set up in the male or female germline (19). Some
rare SRS patients carry maternal microduplications of 11p15
encompassing CYCLIN DEPENDENT KINASE INHIBITOR 1C
(CDKN1C), POTASSIUM CHANNEL, VOLTAGE GATED KQT-LIKE
SUBFAMILY Q, MEMBER 1 (KCNQ1), PLECKSTRIN HOMOLOGY-LIKE
DOMAIN, FAMILY A, MEMBER 2 (PHLDA2) and SOLUTE CARRIER
FAMILY 22, MEMBER 18 (SLC22A18) (20–22). CDKN1C is a mater-
nally expressed gene (23,24) and these SRS patients are predicted
to have twice the normal level of CDKN1C expression (25,26).
Mutations in the CDKN1C coding region have been observed in
some patients with an IMAGe syndrome (MIM 614732), another
complex growth restriction disorder whose early clinical fea-
tures, including IUGR, overlap with that of SRS (27,28). In contrast
to the functionally inactivating mutations reported in the con-
genital overgrowth disorder Beckwith-Wiedemann syndrome
(BWS, MIM 130650) (29–33), studies suggest increased protein sta-
bility in IMAGe syndrome (28,34) consistent with a role for
CDKN1C in growth restriction (35).
Loss of Cdkn1c has been extensively studied in mouse mod-
els, which have highlighted in a role in a number of key features
of BWS, including foetal overgrowth and disrupted placental de-
velopment (36–40). We have recently reported on the phenotype
of a mouse, which models the maternal microduplications on
11p15 that are reported in some cases of SRS (41). These mice
carry a bacterial artificial chromosome (BAC) transgene provid-
ing extra active copies of Cdkn1c, Slc22a18 and Phlda2
(Cdkn1cBACx1), are growth restricted in utero and remain small
throughout their lives (39). In addition, these mice show neona-
tal hypoglycaemia, head-sparing, a significant loss of white adi-
pose tissue all of which are reported in SRS (41). These mice also
possess larger brown adipose tissue depots (41), a phenotype not
yet explored in SRS. We were able to attribute all these pheno-
types to the just two-fold elevated expression of Cdkn1c using a
second BAC line of mice that carries exactly the same transgene,
but with the transgenic expression of Cdkn1c replaced by a b-ga-
lactosidase reporter gene (Cdkn1cBACLacZ) (42). Phenotypes present
in the Cdkn1cBACx1 transgenic line and absent in the
Cdkn1cBACLacZ transgenic line were due to the increased expres-
sion of Cdkn1c. The presence of some defining SRS features in
our unique model supported a role for elevated CDKN1C in SRS
(41). As we describe here, this model also provides a unique and
timely opportunity to assess behaviour in an SRS model, and
more specifically in relation to elevated Cdkn1c. We found that
Cdkn1cBACx1 animals were hypoactive, had impaired sensorimo-
tor gating and a blunted hedonic response to a palatable solu-
tion. Finally, all deficits were rescued by ablation of the
additional copy of Cdkn1c strengthening a causal relationship
between dosage of this gene and potential behavioural abnor-
malities in SRS.
Results
Cdkn1cBACx1 animals display hypoactivity unrelated to
motor dysfunction
In light of reports of hyperactivity in some SRS patients, we first
assessed basic motor function in Cdkn1cBACx1 animals, both in
terms of general activity levels and motoric competence. We as-
sayed basal activity for 2-hours on three consecutive days using
a standardised general measure where movement is detected by
consecutive breaks of two infrared beams (‘run’) (43). Cdkn1cBACx1
mice were hypoactive relative to their WT littermates, overall
making nearly half as many runs in any given session (main
effect of GENOTYPE: F1,47¼8.49, P¼ 0.005) (Fig. 1A and B).
This hypoactive phenotype was consistent and not related to a
differential reactivity to novelty as, although all animals showed
the expected reduction in activity during the first session (Fig.
1A; main effect of BIN, F23,1081¼38.6, P< 0.001) and across the
three consecutive days of testing (Fig. 1B; main effect of DAY,
F2,94¼14.6, P< 0.001), there was no interaction with GENOTYPE
(BIN*GENOTYPE, F23,1081¼0.61, P¼ 0.92; DAY*GENOTYPE
F2,94¼0.842, P¼ 0.43).
The hypoactivity of Cdkn1cBACx1 mice was not related to a
general impaired motoric function. Firstly, all animals showed
the expected increase in number of runs in response to amphet-
amine (main effect of DRUG: F1,47¼5.9, P¼ 0.019), and this re-
sponse was not different by genotype (DRUG*GENOTYPE
interaction: F1,47¼0.01, P¼ 0.94) (Fig. 1C). Secondly, explicit mea-
sures of motoric function on the rotarod implied no general mo-
tor deficits. Animals were trained to walk on a rotating rod that
accelerated across the session duration. All animals learned the
task, as indicated by an increase in latency to first fall across five
training sessions (main effect of SESSION, F1,27¼29.1, P< 0.001),
but there was no main effect of genotype in latency to first fall
across the training sessions (main effect of GENOTYPE,
F1,27¼1.92, P¼ 0.18) and no SESSION*GENOTYPE interaction
(F4,108¼1.81, P¼ 0.13). (Fig. 1D). Moreover, during accelerating
rotarod probe tests following training, there was no effect of
GENOTYPE on latency to fall across five test rotation speeds
(main effect of GENOTYPE: F1,27¼1.47, P¼ 0.24; Fig. 1E).
Emotional reactivity is not altered in Cdkn1cBACx1
animals
Emotional reactivity was assessed using the elevated plus maze
test (EPM) and the open field (OF) test. In the EPM, all animals
showed the expected pattern of behaviour, spending less time
on the anxiogenic open arm than other areas of the maze (mid-
dle section, closed arm). Although Cdkn1cBACx1 animals spent
35% less time on the open arm of the maze on average than
their WT littermates (Fig. 2A), this failed to reach significance
(t(53)¼1.73, P¼ 0.09). A lack of an altered emotional reactivity
between Cdkn1cBACx1 and WT animals on the EPM test was fur-
ther underlined by no effect of GENOTYPE on number of entries
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to the open arms (t(53)¼1.49, P¼ 0.14) (Fig. 2B) and latency to en-
ter open arms (t(53)¼-0.43, P¼ 0.67) (Fig. 2C).
Similarly, the OF test revealed no significant difference be-
tween Cdkn1cBACx1 animals and their WT littermates in the time
spent in the anxiogenic inner zone of the arena (t(53)¼0.59,
P¼ 0.56; Fig. 2D). Again, there was no effect of genotype on num-
ber of entries to the inner zone (t(53)¼1.41, P¼ 0.16; Fig. 2E) nor
in latency to enter open arms (t(53)¼0.23, P¼ 0.82; Fig. 2F).
These data, from two separate tests, indicate that in emotional
reactivity and anxiety behaviours do not differ between
Cdkn1cBACx1 animals and their WT littermates. Consequently,
the observed hypoactivity in Cdkn1cBACx1 was not explained by a
difference in the state of anxiety.
Cdkn1cBACx1 animals have sensorimotor gating deficits
Impairments in sensorimotor gating have been described in asso-
ciation with a number of neurodevelopmental disorders includ-
ing schizophrenia (44) and autism spectrum disorders (45). As
like many other studies of mouse models of neuropsychiatric (46)
and neurodevelopmental disorders (47), we measured the acous-
tic startle response (ASR) and the prepulse inhibition (PPI) of the
ASR to infer changes in sensorimotor gating here. There was no
difference in ASR at 105dB between Cdkn1cBACx1 and WT
littermates (Fig. 3A; t(29)¼1.22, P¼ 0.23). However, PPI of the ASR
was attenuated by almost half in Cdkn1cBACx1 relative to WT lit-
termates (Fig. 3B; main effect of GENOTYPE: F1,29¼6.264,
P¼ 0.018). This reduction in PPI in Cdkn1cBACx1 animals followed
the expected pattern of further inhibition with increasing pre-
pulse (main effect of PRE-PULSE: F2,58¼22.926, P< 0.001), and was
consistent across the range of pre-pulses used
(PREPULSE*GENOTYPE F2,58¼1.244, P¼ 0.296). This pattern of
change with increasing prepulse indicate that Cdkn1cBACx1 ani-
mals are unlikely have a general hearing impairment but that,
taken together, these data suggest an impaired sensorimotor gat-
ing response relative toWT littermates.
Impaired perceived palatability in Cdkn1cBACx1 animals
Parents of children with SRS often report feeding difficulties
with the term fussy eaters commonly used to describe this
behaviour (15). We previously reported no difference in the con-
sumption of standard chow by Cdkn1cBACx1 mice (41). In a stan-
dard two-bottle preference test, we extend this finding to
palatable foods (8% sucrose), showing that both Cdkn1cBACx1 ani-
mals and their WT littermates preferred sucrose over water
(Z¼ 82, P¼ 0.01) (Fig. 4A), but with no effect of genotype (U¼ 75,
P¼ 0.2). However, measures of consumption do not directly
Figure 1. Cdkn1cBACx1 animals display hypoactivity unrelated to any motoric function deficits. (A) Locomotor activity data on the first day of testing broken down into 5-
minute bins shows consistent reduced activity of Cdkn1cBACx1 mice relative to WT littermates throughout the session. (B) Cdkn1cBACx1 also displayed consistent hypoac-
tivity across three consecutive test days. (C) All animals showed the expected increase in activity after amphetamine administration. (D) Reduced activity in
Cdkn1cBACx1 mice was not related to motoric function deficits as all animals increase time before first fall following successive rotatod training session. (E) Similarly,
there was no effect of genotype on latency to fall from an accelerating rotarod across a range of test speeds. Data shown is6SEM. Main effect of GENOTYPE, *¼ P<0.05,
**¼ P< 0.01; main effect of within subject factors (BIN, SESSION, DOSE, SPEED) #¼ P< 0.05, ###¼ P<0.001.
3Human Molecular Genetics, 2016, Vol. xx, No. xx |
 at A
cquisitions on January 16, 2017
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
provide an indication of the hedonic response to food. To ad-
dress this, we made use of lick cluster size analysis (LCA).
Rodent consumption of a freely available solution is a highly
stereotyped behaviour with mice and rats licking in clusters
with regular intercluster intervals. LCA can be used as a proxy
measure of the perceived palatability of that solution where the
average lick cluster size made in response to a palatable solu-
tion is related to the hedonic properties of that solution (48). As
expected, as the concentration of the sucrose solution in-
creased, there was an overall increase in the average lick cluster
size for both groups (Fig. 4B; main effect of CONCENTRATION:
F3,162¼27.1, P< 0.001). However, the Cdkn1cBACx1 mice had a
smaller average lick cluster sizes compared to their WT litter-
mates (main effect of GENOTYPE, F1,54¼5.11, P¼ 0.028), which
was steady across all the four sucrose concentrations assessed
(CONCENTRATION*GENOTYPE, F3,162¼1.347, P¼ 0.26). There
was no significant difference between Cdkn1cBACx1 males and
their wt littermates in total number licks (main effect of
GENOTYPE, F1,54¼1.281, P¼ 0.26) or in total number of bouts
(main effect of GENOTYPE, F1,54¼0.008, P¼ 0.93). Consistent
with other measures of feeding, there was no significant differ-
ence overall consumption of the solution (Fig. 4C; main effect of
GENOTYPE, F1,54¼1.515, P¼ 0.224), which excludes an altered
satiety threshold underlying the decreased lick cluster size.
Critically, there was no effect of genotype on the inter lick inter-
val (ILI; main effect of GENOTYPE: F1,54¼1.16, P¼ 0.29) (data not
shown). ILI is a measure of the mechanical task of the per-
formance. As the ILI was the same in both genotypes, this ex-
cludes the difference in licking being as a result of a physical
incapacity. Together, these data suggest that the Cdkn1cBACx1
mice perceived a lower palatability of a sucrose solution com-
pared to WT littermates.
To ask whether the effect of Cdkn1c on feeding was associ-
ated with alterations in the brain related to feeding and
dopamine-signalling, associated with food reward processing in
the brain (49), we examined two regions of the hypothalamus
involved in the regulation of food intake, the A13 dopaminergic
cell group in the zona incerta and periventricular hypothalamus
(50–52). Expression of tyrosine hydroxylase (Th), an enzyme in-
volved in the synthesis of dopamine and noradrenaline, was
used as a marker of these cell types. There was a significant in-
crease in tyrosine hydroxylase (Th)-positive cells, in the peri-
ventricular hypothalamus (t(8)¼ 2.29, P¼ 0.05) of Cdkn1cBACx1
with no significant change in the A13 dopaminergic cell group
(t(8)¼1.48, P¼ 0.18) (Fig. 4D). This altered neurobiology could
contribute to the changes in hedonic behaviour.
Behavioural deficits in Cdkn1cBACx1 animals are directly
attributable to increased Cdkn1c dosage
The Cdkn1cBACx1 mouse models the rare 11p15 microduplication
seen in a small number of SRS patients (20–22). In this mouse
model, as in these rare SRS patients, more than one gene is pre-
sent within the duplicated region. We wanted to delineate the
contribution of these genes, in particular focusing on one,
namely Cdkn1c, which has a well described role in brain func-
tion (53,54). To isolate the contribution of elevated Cdkn1c ex-
pression to the behavioural phenotypes, we utilized an animal
model carrying a single copy of the transgene spanning Cdkn1c,
but with the transgenic Cdkn1c copy ablated. In this model,
Cdkn1c is expressed at wild type levels (39,41). Critically, none
of the behavioural differences found in Cdkn1cBACx1 were repli-
cated in this model. Specifically, there was no difference in ac-
tivity between Cdkn1cBACLacZ animals and their WT littermates
(Fig. 5A; main effect of GENOTYPE: F1,28¼0.46, P¼ 0.52). There
was no difference in time spent in (t(54)¼-0.14, P¼ 0.89) or fre-
quency of entries to (t(54)¼1.15, P¼ 0.25) the open arms of an
EPM (Fig. 5B and C), with convergent findings from the OF
test, with no difference in time spent in (t(54)¼0.24, P¼ 0.81) or
frequency of entries to (t(54)¼0.18, P¼ 0.86) the internal zone
(Fig. 5D and E). Sensorimotor gating deficits observed in
Cdkn1cBACx1 animals were normal in Cdkn1cBACLacZ animals
Figure 2. Emotional reactivity was intact in Cdkn1cBACx1 animals. There were no
differences between Cdkn1cBACx1 animals and their WT littermates in measures
on the EPM test, including (A) time spent on open arm, (B) entries into open arm
and (C) latency to first enter open arm. Similarly, there were no differences be-
tween Cdkn1cBACx1 animals and their WT littermates in measures on the OF test,
including (D) time spent in centre zone, (E) entries into centre zone, and (F) la-
tency to first enter centre zone. Data shown is6SEM.
Figure 3. Elevated Cdkn1c expression results in sensorimotor gating deficits. (A)
Average ASR to a 105dB pulse was not affected by genotype (B). However, PPI of
the startle response was significantly blunted in Cdkn1cBACx1 animals. Data
shown is6SEM. Main effect of GENOTYPE, *¼ P<0.05; main effect of PPI, ##¼
P<0.01.
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with no difference in ASR at 105 dB (Fig. 5F; t(29)¼ 0.58, P¼ 0.56)
and PPI (Fig. 5G; main effect of GENOTYPE: F1,28¼2.97, P¼ 0.10).
Finally, perceived palatability of a sucrose solution, as mea-
sured by LCA, was also equivalent between Cdkn1cBACLacZ ani-
mals and their WT littermates (Fig. 5H; main effect of
GENOTYPE, F1,51¼2.9, P¼ 0.1) and there was no difference in
consumption within the LCA test (Fig. 5I; F1,51¼2.46, P¼ 0.12).
These data demonstrate that the behavioural abnormalities
observed in the Cdkn1cBACx1 mouse model are attributable spe-
cifically to the elevated expression of Cdkn1c.
Discussion
In these experiments we took advantage of a transgenic mouse
line that effectively models a rare molecular subtype of patients
diagnosed with SRS. These mice carry a single extra copy of a
transgene spanning three imprinted genes Cdkn1c, Phlda2 and
Slc22a18 with the minimal duplicated region in SRS spanning
one additional gene, Kcnq1. We used this model to assess rele-
vant phenotypes concerning activity, emotional reactivity, sen-
sorimotor gating and consumption and response to palatable
food. We found selective effects, with the model being generally
hypoactive with no obvious deficits in motoric ability, reduced
PPI of an ASR and a reduced perceived palatability to sucrose.
The extent to which discrete aspects of behaviour could be re-
lated to specific gene effects was assessed using a second model
in which only Phlda2 and Slc22a18were elevated. The absence of
alterations in these specific behaviours in this second model
identifies elevated Cdkn1c as the causal mutation. In addition to
demonstrating the behavioural consequences of increased
Cdkn1c expression, these data suggest expanding the clinical
phenotype assessment of SRS to include more neurological and
behavioural measures.
Increased activity has been reported in some patients with
SRS, while other studies fail to report an association. Our data
on the Cdkn1cBACx1 model indicated reduced, rather than in-
creased, baseline activity. Although Cdkn1cBACx1 mice showed
the normal reduction in activity over time as they habituated to
the apparatus, their general hypoactivity was consistent
throughout the first session and across the three consecutive
daily sessions. This suggests that this locomotor activity pheno-
type was not related to any altered reactivity to novelty or in-
creased anxiety. This idea was supported by data from explicit
tests of emotional reactivity, the elevated plus maze and open
field, where there were no differences in behaviour between
Cdkn1cBACx1 mice and their WT counterparts. Furthermore, the
reduced activity was not due to a physical impairment, as
Cdkn1cBACx1 mice increased their locomotor activity in a similar
pattern to WT after acute amphetamine administration and
also showed no difference in motor learning and skill on the
rotarod test. Reports of hyperactivity in individuals with SRS are
infrequent, however, why there should be a discrepancy
Figure 4. Cdkn1cBACx1 animals show a reduced perceived palatability of a sucrose solution. (A) All animals preferred sucrose to water and this was not affected by geno-
type. (B) Cdkn1cBACx1 animals had consistently smaller average lick cluster size compared to WT indicating altered hedonic processing. (C) Despite potentially reduced
perceived palatability, consumption of a palatable solution was not different between Cdkn1cBACx1 animals and WT. (D) Cdkn1cBACx1 had significantly more Th-positive
cells that wt in the periventricular hypothalamus (PVH), but not the A13 dopaminergic cell group. (E) Representative images showing Th staining. Scale bar is 100lm.
Data shown is6SEM. Main effect of GENOTYPE, *¼P0.05; main effect of concentration ##¼ P<0.01.
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between reports of hyperactivity in some SRS patients and ro-
bust evidence of hypoactivity in the Cdkn1cBACx1 SRS mouse
model is not clear. This may relate to reporting (as opposed to
explicit measures of activity) and/or whether the genetic sub-
types of SRS have been taken into account.
Sensorimotor gating, as measured here by PPI of the ASR,
provides a measure of appropriate integration of sensory cues
with a motor output. Although we found no difference in the re-
sponse to an acoustic startle, Cdkn1cBACx1 mice did show a re-
duced PPI. Cdkn1cBACx1 mice did show the expected increase in
PPI of startle in response to an increasingly loud pre-pulse tone,
but there was a general reduction in the degree of inhibition.
This suggests the reduced PPI is not due to hearing problems in
the Cdkn1cBACx1 mice, but is more likely to be related to specific
deficits in sensorimotor gating. This pattern of abnormalities is
seen in a number of psychiatric disorders (44) and also autism
spectrum disorders (45). Although the incidence of psychiatric
illness in SRS is very rare (55), there are a growing number of
studies beginning to link SRS with neurodevelopmental disor-
ders, such as autism spectrum disorders (56).
One of the more widely reported behaviours in SRS relates to
difficulties with food; fussiness with regards to food, and chil-
dren who are simply not interested in food. Since a key compli-
cation in SRS is the failure to gain weight and extreme
skinniness, it is important to understand the biology underpin-
ning this behaviour. We previously reported that Cdkn1cBACx1
mice possess more energy consuming brown adipose tissue but
consumed the same amount of standard chow as their
littermates over a 7-day measurement (41). This could account
for the low BMI reported in SRS but would not explain fussy eat-
ing. Here, we show that consumption of a palatable sucrose so-
lution was equivalent between Cdkn1cBACx1 and WT littermates.
However, consumption does not provide a measurement of the
hedonic response to food. In order to test this, we made use of
LCA, a behavioural measure of perceived palatability (48) used
previously to examine rodent models of psychiatric disorders
(57) and the imprinting disorder, Prader Willi Syndrome (58).
Rodents rarely show continuous consumption of a liquid.
Instead they perform repeated clusters of licks separated by
pauses. The number of licks in each cluster (cluster size) has a
positive, monotonic relationship with the concentration of a
palatable solution such as sucrose (59). Importantly, cluster size
is not simply a reflection of the amount consumed. For example,
although the cluster size increases with increased sucrose con-
centration, the amount consumed varies in an inverted U-
shaped function. In addition, studies of conditioning have also
shown that cluster size measures of hedonic reactions and con-
sumption measures can dissociate (60). Therefore, the cluster
size is a sensitive measure of the palatability of a solution. Here
we show that, although Cdkn1cBACx1 mice consumed the same
volume of a sucrose solution, they did so in smaller lick clusters.
This indicates that perceived palatability in Cdkn1cBACx1 mice is
reduced relative to WT littermates; for instance Cdkn1cBACx1
mice have a similar lick cluster size at 8% sucrose as WT mice at
4% sucrose (Fig. 4B). This would suggest perturbed food reward
processing in the Cdkn1cBACx1 mice, with effects on the perceived
Figure 5. Behavioural alterations in Cdkn1cBACx1 animals were absent when Cdkn1c expression was not elevated. (A) There was no difference between Cdkn1cBACLacZ ani-
mals and their WT littermates in LMA. (B–E) Duration of time spent in and number of entries into an anxiogenic zone was not affected by genotype in an (B,C) EPM or
(D,E) OF. (F,G) ASR and PPI was not different between Cdkn1cBACLacZ animals and WT littermates. Average lick cluster size (H) was equivalent between groups, as was
consumption (I) of a palatable sucrose solution. Data shown is6SEM. Main effects of within subject factors (PPI, Concentration) ###¼ P<0.001.
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hedonic value of food. In human studies, it has been demon-
strated that there is a positive relationship between food palat-
ability and amount consumed (61). In human SRS patients, it is
easy to imagine how a lowered hedonic response may translate
into fussiness or a disinterest in food and, consequently, re-
duced food intake.
One of the complexities of studying any phenotype associ-
ated with an imprinting disorder, such as SRS, is the potential
involvement of multiple genes. As previously (41), we were able
to address this issue using a separate control line of transgenic
mice carrying the same BAC transgene, but without elevated ex-
pression of Cdkn1c (Cdkn1cBACLacZ). The behaviour of the
Cdkn1cBACLacZ mice was equivalent to WT in all of the behaviou-
ral tests described here. These data implicate over-expression
of Cdkn1c as the critical molecular factor underlying the hypoac-
tivity, reduced PPI and lowered hedonic response to sucrose
seen in the SRS model, the Cdkn1cBACx1 mice. This is perhaps
unsurprising, given the minimal brain expression of the other
BAC genes, Phlda2 and Slc22a18. In contrast, Cdkn1c has a key
role in the developing nervous system through the regulation of
cell cycle exit, differentiation and migration of embryonic cere-
bral cortical precursors (54), with loss-of-function resulting in
an increased thickness of layer six of the cortex during develop-
ment (62). In addition to early development, Cdkn1c has also
been shown to be key to the regeneration of the adult brain
through regulating adult neural stem cell quiescence (63). The
functional relevance of this role in adult neural stem cells has
not been explored in relation to behaviour but there may be fur-
ther influences on behaviour as the mice age or under specific
conditions where appropriate neurogenesis is required e.g.
learning and memory (64). However, possibly most pertinent to
the behaviours outlined here is the role of Cdkn1c in the devel-
oping dopaminergic system. For instance, Cdkn1c co-expression
with Nurr1 promotes maturation of a midbrain dopaminergic
neuronal cell line while loss-of-function in vivo results in the
failure of this cell types to differentiate in a timely manner (53).
Perturbation of the dopamine systems has long been linked to
changes in locomotor activity (65,66) and sensorimotor gating
(67,68). Dopamine signalling is also associated with food reward
processing in the brain (49). We show an increase in the number
of Th-positive cells in the A13 dopaminergic cell group and peri-
ventricular hypothalamus. As Th is marker for both dopaminer-
gic and noradrenergic neurons, and the observation that Cdkn1c
is involved in embryonic dopaminergic cell proliferation, this
indicates that the development of the dopaminergic system
may be compromised in mice over-expressing Cdkn1c.
Moreover, given the role of the hypothalamus in the regulation
of food intake (50–52), the increased number of Th-positive cells
in these regions may contribute to this phenotype.
Patients with microduplications spanning CDKN1C are very
rare (20–22). The majority of SRS patients do not carry genetic
mutations affecting CDKN1C or epigenetic alterations at the im-
printing centre for CDKN1C (KCNQ1OT1:TSS-DMR), which lies
over 200kb away from the gene (69,70). A key question that this
study raises, therefore, is the extent to which elevated CDKN1C
contributes more widely to SRS. Loss of paternal silencing in
mice can occur in circumstances where DNA methylation at the
imprinting centre is intact. For example, when the non-coding
RNA Kcnq1ot1/Lit1 is prematurely terminated (71,72), when DNA
methylation is not maintained in the somatic DMR in the pro-
motor of Cdkn1c (73–75) and when repressive histone marks are
not propagated (76). Therefore biallelic expression of CDKN1C in
humans could occur independent to changes in KCNQ1OT1:TSS-
DMR methylation. CDKN1C levels have not been extensively
examined in patients with (epi)mutations at the locus 11p15 lo-
cus or in those 40% of patients without an identified genetic or
epigenetic defect. Further work is required to establish the prev-
alence of elevated CDKN1C in SRS and the extent to which our
behavioural observations may inform the assessment of these
patients. Nonetheless, there is now a considerable body of evi-
dence from animal models and human studies to indicate a role
for the imprinted CDKN1C gene in at least three very rare disor-
ders affecting foetal growth (SRS, BWS and IMAGe) syndrome.
Importantly, the new knowledge presented in this study will
contribute to an improved understanding of the long-term
behavioural implications for all these disorders.
In summary, we present the first characterisation of rodent
behaviour in response to elevated expression of the imprinted
Cdkn1c gene, which identified alteration in in locomotor activity,
sensori-motor gating and the hedonic response to food.
Although we do not characterise the specific neural perturba-
tion in this model in detail, we observed alterations in a number
of Th-positive neurons in the hypothalamus suggesting a direct
effect on the developing central nervous system. Further work
is required to clarify the relationship between elevated CDKN1C
and SRS with a specific reference to neurodevelopmental prob-
lems. Indeed, different genetic sub-types of SRS may present
with differing ranges of additional problems, as has been sug-
gested previously with respect to SRS scoring system (4). Our
data strongly suggest that this would be an avenue of research
worth exploring. A better understanding of the pathobiology
underpinning any behavioural and cognitive abnormalities, and
food disorders in particular, in SRS patients will be helpful in
the design of therapeutic approaches in the longer term.
Materials and Methods
Animals
The experimental line Cdkn1cBACx1 possesses one copy of a bac-
terial artificial chromosome that spans the Cdkn1c gene and two
other genes, Phlda2 and Slc22a18. The reporter line Cdkn1cBACLacZ
possesses a modified version of this BAC with a b-galactosidase
reporter construct inserted into the Cdkn1c locus, disrupting
Cdkn1c expression (27). Cdkn1cBACLacZ functions as a control for
the experimental line to attribute any phenotypes observed spe-
cifically to the over expression of Cdkn1c (i.e. present in line
Cdkn1cBACx1 and absent in line Cdkn1cBACLacZ). Both lines were
maintained on a C57BL/6 background having been bred onto
this background for>12 generations. One hundred and twenty-
nine male mice were used for behavioural assessment:
Cdkn1cBACx1 (n¼ 40), WT littermates (n¼ 36), Cdkn1cBACLacZ
(n¼ 31) WT littermates (n¼ 22). For all testing minimum group
size per genotype was 13. Degrees of freedom is stated in all sta-
tistical analysis reflecting the total group size.
LMA and motoric function
LMA behaviour was tested using as described (43) with two
infra-red beams crossing each cage 30mm from each end and
10mm from the floor of the chamber. Beam breaks were re-
corded as an indication of activity, using a computer running
custom written BBC Basic V6 programmes with additional inter-
facing by ARACHNID (Cambridge Cognition Ltd, Cambridge,
U.K.). Data stored were the total number of beam-breaks in a
2hour session. One session was carried out per day, for three
consecutive days as a measure of habituation to a novel
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environment. Habituation to a novel arena was assayed by the
decrease in beam breaks across sessions.
Following the three days of basal locomotor activity testing,
animals were injected intra-peritoneally (i.p.) with saline or
1mg/kg of D-amphetmine sulphate (Tocris Bioscience, Bristol,
UK). All animals received each solution in a pseudo-randomised
order, with 72hours between each injection to allow for solution
wash out. Session total consecutive beam breaks (runs) were
used as an indication of amphetamine induced LMA. A rotarod
task (Ugo Basile, Italy) was used to assess motoric function.
Animals received five training sessions. In the test session la-
tency to fall at a set rotating speed was recorded.
Emotional reactivity
EPM
Anxiety was measured using an EPM. Briefly, apparatus, con-
sisting of four Perspex arms two open (175  78mm) and two
enclosed (190  80  150mm) with an open roof, was used.
Animals were placed centrally at the beginning of a trial and al-
lowed to explore freely for 300 s. Activity was tracked using
ETHOVISION software (Noldus, Nottingham, UK). Increased
time spent in the open arm was considered less anxious
behaviour.
OF test
Locomotor activity and anxiety were measured using distance
moved in, and time spent in the centre of, respectively, an OF.
Briefly, an OF apparatus (750  750mm) was used, divided into 2
virtual zones, an inner (central 450  450mm) and an outer
(150mm periphery). Animals were allowed to explore the arena
freely for 600 s and activity was tracked using ETHOVISION soft-
ware (Noldus, Nottingham, UK). Greater time spent in the inner
zone was considered less anxious behaviour.
ASR and PPI
ASR and PPI were monitored using a SR-Lab apparatus (San
Diego Instruments, U.S.A) modified for use in mice. Animals
were placed in a Perspex tube (internal diameter 35mm) and
white noise stimuli were presented via a speaker. Pulse-alone
trials consisted of a 40ms startle stimulus and a prepulse trial
consisted of a 20ms prepulse at 4, 8, or 16db above background
and a 40ms 105db startle stimulus, 70ms after the prepulse. The
stimuli were presented in a pseudorandom manner every 15s.
Whole body startle responses were recorded as the average
startle during a 65ms window timed from the onset of the star-
tle pulse. PPI was calculated as the percentage reduction in star-
tle between prepulse trials and pulse alone trials.
Preference testing
Mice had restricted food access for the duration of testing, hav-
ing no access to food for 16hours prior to testing. All testing
took place in opaque Perspex boxes with access to the solution
provided for thirty minutes, once per day. Preference testing
was carried out on seven consecutive days. For three days mice
were presented with two bottles of water to ensure there was
no side bias. For the following four consecutive days one bottle
contained an 8% (w/v) sucrose solution, which altered left-right
presentation by day. Bottles were weighed before and after test-
ing and sucrose preference was calculated as (volume sucrose
consumed/total volume consumed)*100.
Lick cluster analysis
LCA testing was carried out as described (58) with food restric-
tion as in preference testing. A contact sensitive lickometer reg-
istered each lick to the nearest 0.01 s, recorded using MED-PC
software (Med Associates Inc., St. Albans, VT, USA). Animals
were trained to drink 8% (w/w) sucrose in water prior to testing,
until consumption had stabilised (requiring 4–14 sessions).
Animals were presented with a solution of a given sucrose con-
centration for a minimum of four days; the order of presenta-
tion was counterbalanced for genotypes. Sessions in which
data records indicated errors in lick recording or spout blockage
were removed from the analysis; specifically recording fewer
than 10 bouts, greater than 40 isolated single licks or average
interlick intervals of<90 or>250ms. This equated to the exclu-
sion of 48/721 data points for Cdkn1cBACx1 animals and WT lit-
termates and 117/752 data points for Cdkn1cBACLacZ animals.
Inclusion of these data points does not alter the result.
The data from the first day at each new concentration was ex-
cluded. Data were averaged across sessions at each concentra-
tion for comparison. A pause between licks of greater than 0.5 s
was defined as a new cluster.
Immunohistochemistry
Animals were transcardially perfused with 10% formalin fixa-
tive (Sigma-Aldrich, UK) and brains removed. Following post-
fixing overnight, brains were removed to a solution of PBS con-
taining 30% sucrose. 40 lm sections were obtained from
Bregmaþ2 to 2.5 on a freezing microtome. Immunostaining
for Th was carried out on 1 in 5 sections (every 120lm). Free-
floating sections were incubated overnight in 1:1000 rabbit-a-Th
(Abcam, UK) and section was performed using standard DAB
staining (Vector labs). Number of positive cells in A13 dopam-
nergic cell group of the zona incerta and periventricular hypo-
thalamus were counted on all sections.
Statistics
All statistical analyses were carried out using SPSS 20.0 (SPSS,
USA). Simple effects were analysed by Students t-test. For re-
peated behavioural analysis a series of ANOVAs were carried
out on the data with a between subject factor of GENOTYPE and
within subjects factor of CONCENTRATION/DAY/BIN/PRE-PULSE
INTENSITY, where appropriate. Sucrose preference data and ef-
fect of genotype on preference were analysed using Wilcoxon
signed rank and Mann-Whitney U-tests, respectively.
Differences in Th immunoreactivity was analysed by Students
t-test.
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